Related Experiment Video
Updated: May 27, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Acute lymphoblastic leukemia in adults.
1Clinical Hematology Department, Institut Catala d'Oncologia, Hospital Universitari Germans Trias i Pujol, Badalona, Spain;
Pediatric Reports
|November 5, 2011
Summary
Acute lymphoblastic leukemia (ALL) treatment advances, particularly in adults, involve adapting pediatric regimens and improving supportive care. Minimal residual disease monitoring and targeted therapies offer future hope for better outcomes.
Area of Science:
- Hematology
- Pediatric Oncology
- Clinical Research
Background:
- Acute lymphoblastic leukemia (ALL) is a common childhood cancer, but rare in adults.
- Pediatric ALL treatment advances primarily stem from optimizing existing therapies.
- Recent years have seen improvements in adult ALL outcomes.
Purpose of the Study:
- To review recent advances in the treatment of acute lymphoblastic leukemia (ALL).
- To discuss the application of pediatric regimens in adult ALL.
- To highlight emerging therapeutic strategies and supportive care improvements.
Main Methods:
- Review of current literature on pediatric and adult ALL treatment.
- Analysis of advances in supportive care for stem cell transplantation (SCT).
- Evaluation of novel therapeutic agents and diagnostic tools.
Main Results:
- Pediatric regimens show promise for improving adult ALL outcomes.
- Advances in SCT, including reduced-intensity conditioning, expand treatment options.
- Minimal residual disease (MRD) evaluation aids risk stratification.
- New drugs like tyrosine kinase inhibitors and monoclonal antibodies offer incremental benefits.
Conclusions:
- Adapting pediatric protocols and enhancing supportive care are key to improving adult ALL outcomes.
- MRD monitoring and targeted therapies based on genetic/epigenetic understanding hold significant promise.
- Future treatments aim for more effective disease control with reduced toxicity.
Related Concept Videos
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...